Aspasia Stamatoullas Selected Research

eprenetapopt

10/2021

Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aspasia Stamatoullas Research Topics

Disease

28	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2002
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2004
9	Neoplasms (Cancer) 10/2021 - 07/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 03/2006
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2016
3	Infections 07/2022 - 05/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 01/2016
3	Anemia 01/2018 - 07/2004
3	Lymphoma (Lymphomas) 04/2016 - 04/2009
2	Febrile Neutropenia 10/2021 - 05/2015
2	Residual Neoplasm 01/2021 - 01/2016
2	Pathologic Complete Response 01/2018 - 01/2017
2	Disease Progression 05/2017 - 03/2017
2	Thrombocytopenia (Thrombopenia) 03/2017 - 01/2004
2	Sarcopenia 07/2014 - 04/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2004 - 01/2004
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022
1	Iron Overload 10/2019
1	Fatigue 07/2019
1	Infertility (Sterility) 01/2019
1	GATA2 Deficiency 01/2019
1	Fever (Fevers) 08/2018
1	Candidiasis (Moniliasis) 08/2018
1	Hemorrhage 03/2017
1	Inflammation (Inflammations) 01/2017
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2017
1	Thalassemia 01/2017
1	Hypoalbuminemia 01/2016
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2016
1	Invasive Pulmonary Aspergillosis 06/2015
1	Invasive Fungal Infections 06/2015
1	Mycoses (Diseases, Fungus) 06/2015
1	Cachexia 07/2014
1	Sepsis (Septicemia) 06/2014
1	Peritonitis 06/2014
1	Primary Ovarian Insufficiency 01/2012
1	Abnormal Karyotype 01/2011
1	beta-Thalassemia (Cooley's Anemia) 07/2010

Drug/Important Bio-Agent (IBA)

8	Azacitidine (5 Azacytidine)FDA Link 10/2021 - 01/2011
6	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2015
5	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 06/2017
5	Lenalidomide (CC 5013)FDA Link 02/2018 - 04/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2017
4	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 06/2017
4	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2012 - 01/2004
3	HematinicsIBA 12/2020 - 05/2017
3	IronIBA 10/2019 - 07/2010
3	Prednisone (Sone)FDA LinkGeneric 01/2019 - 01/2018
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2004
3	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2016
3	CytokinesIBA 01/2018 - 05/2007
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 09/2005
2	Brentuximab VedotinIBA 01/2022 - 04/2016
2	Biological ProductsIBA 07/2019 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2019
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 01/2019
2	Procarbazine (Matulane)FDA Link 01/2019 - 01/2019
2	Exportin 1 ProteinIBA 01/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2016
2	Rituximab (Mabthera)FDA Link 07/2014 - 04/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2008 - 07/2004
2	Erythropoietin FDA Link 01/2008 - 07/2004
1	BNT162 VaccineIBA 01/2022
1	NivolumabIBA 01/2022
1	VaccinesIBA 01/2022
1	Pharmaceutical PreparationsIBA 10/2021
1	eprenetapoptIBA 10/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	acadesineIBA 12/2019
1	RNA Splicing FactorsIBA 10/2019
1	guadecitabineIBA 01/2019
1	Activin Receptors (Activin Receptor)IBA 02/2018
1	Proteins (Proteins, Gene)FDA Link 02/2018
1	ACE-011IBA 02/2018
1	Epirubicin (Ellence)FDA LinkGeneric 01/2018
1	ruxolitinibIBA 01/2018
1	Investigational DrugsIBA 05/2017
1	Thrombopoietin ReceptorsIBA 03/2017
1	eltrombopag FDA Link 03/2017
1	HepcidinsIBA 01/2017
1	Transferrin (beta 2 Transferrin)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Sodium Glutamate (Accent)IBA 06/2015
1	Fluorine-18IBA 05/2015
1	Bendamustine Hydrochloride FDA Link 11/2013
1	Bortezomib (Velcade)FDA Link 07/2012
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2019 - 01/2002
11	Therapeutics 10/2021 - 01/2002
9	Stem Cell Transplantation 01/2022 - 01/2002
4	Radiotherapy 01/2018 - 04/2014
2	Erythrocyte Transfusion 01/2022 - 06/2010
2	Salvage Therapy 12/2008 - 01/2002
1	Catheters 07/2022
1	Vascular Access Devices (Arterial Line) 07/2022
1	Investigational Therapies (Experimental Therapy) 10/2021
1	Drug Tapering 10/2021
1	Central Venous Catheters 05/2015
1	Chelation Therapy (Therapy, Chelation) 07/2010